Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. · Phase II
716 (USA) · Dr. Ito
consented 2014-05-14
AEs
4
Serious
0
Dropout signal
–
Adverse events
moderate
assessed
Moderate ABDOMINAL PAIN — outcome: RECOVERED/RESOLVED; onset 2014-07-22 (study day 70.0); relationship: NONE
mild
assessed
Mild ERYTHEMA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-05-28 (study day 15.0); relationship: PROBABLE
mild
assessed
Mild ERYTHEMA — outcome: RECOVERED/RESOLVED; onset 2014-05-28 (study day 15.0); relationship: PROBABLE
moderate
assessed
Moderate ULCER — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-08-02 (study day 81.0); relationship: NONE
Data queries
No data queries.